Journal
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
Volume 26, Issue 4, Pages 441-455Publisher
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/S0149-7634(02)00011-8
Keywords
phencyclidine; ketamine; typical antipsychotics; atypical antipsychotics; haloperidol; clozapine; olanzapine; risperidone; 5-HT2A receptors; NMDA receptors; metabotropic-2 glutamate receptors
Categories
Ask authors/readers for more resources
NMDA receptor antagonists worsen symptoms in schizophrenia and induce schizophrenic-like symptoms in normal individuals In animals, NMDA antagonist-induced behavioral responses include increased activity, head weaving, deficits in paired pulse inhibition and social interaction, and increased forced swim immobility. Repeated exposure to NMDA antagonists in animals results in behavioral sensitization-a phenomenon accentuated in rats with dopaminergic neurons lesioned during development. In keeping with an involvement of serotonin and glutamate release in NMDA antagonist action, selected behaviors induced by NMDA antagonists are minimized by 5-HT2A receptor antagonists and mGLU2 receptor agonists These observations provide promising new approaches for treating acute NMDA antagonist-induced psychosis. Further, acute atypical antipsychotic drugs also minimize NMDA antagonist actions to a greater degree than typical antipsychotics. However, because knowledge concerning acute versus chronic effectiveness of various antipsychotic drugs against NMDA antagonist neuropathology is limited, future studies to define more fully the basis of their differences in efficacy after chronic treatment could provide an understanding of their actions on neural mechanisms responsible for the core pathogenesis of schizophrenia. (C) 2002 Elsevier Science Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available